Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867476 · ClinicalTrials.gov registry record

Adherence Monitoring For Substance Abuse Clinical Trials

A clinical trial of Medication Adherence, sponsored by California Pacific Medical Center Research Institute.

Completed
Registry status
8
Enrollment target
1
Study location

NCT01867476 is a study of Medication Adherence that has completed, run by California Pacific Medical Center Research Institute. The registered enrollment target is 8 participants, below the 1,657-participant average among 52 other Medication Adherence trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867476, a study of Medication Adherence, has completed, sponsored by California Pacific Medical Center Research Institute.

COMPLETED
Registry status
8 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

Conditions Studied

Interventions

  • OTHER Automated Adherence Monitoring System

Study Locations (1)

California

  • Addiction & Pharmacology Research Lab, St. Luke's Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2013-01
Est. Completion 2013-02

What the Registry Record Tells You About NCT01867476

The ClinicalTrials.gov registry entry for NCT01867476 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,657-participant average among 52 other Medication Adherence trials with a reported enrollment target (100% lower). The listed sponsor is California Pacific Medical Center Research Institute, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which Automated Adherence Monitoring System is the first listed.

NCT01867476 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01867476 about?

NCT01867476 is a clinical study titled "Adherence Monitoring For Substance Abuse Clinical Trials". The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

What is the current status of trial NCT01867476?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2013-01. Estimated completion is 2013-02.

What conditions does trial NCT01867476 study?

This clinical trial studies the following conditions: Medication Adherence.

What interventions are being tested in trial NCT01867476?

The interventions under investigation include: Automated Adherence Monitoring System (OTHER).

Who is sponsoring clinical trial NCT01867476?

This trial is sponsored by California Pacific Medical Center Research Institute, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01867476 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Medication Adherence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.